Design and development of sequence selective lexitropsin DNA minor groove binders
Identifieur interne : 004057 ( Main/Exploration ); précédent : 004056; suivant : 004058Design and development of sequence selective lexitropsin DNA minor groove binders
Auteurs : J. William Lown [Canada]Source :
- Drug Development Research [ 0272-4391 ] ; 1995-02.
English descriptors
- KwdEn :
Abstract
The concept of lexitropsins, or information‐reading molecules, is introduced within the antigene strategy as an alternative to, and complementary with, the antisense approach for cellular intervention and gene control. Consideration is given to alternative approaches to the development of DNA sequence selective binding agents because of their potential applications in diagnosis and treatment of cancer as well as in molecular biology. The chemical, physical, and pharmacological factors involved in the design of effective lexitropsins are discussed and illustrated with experimental results. Among the factors contributing to the molecular recognition processes are: the presence and disposition of hydrogen bond accepting and donating groups, ligand shape, chirality, stereochemistry, flexibility, and charge. For longer ligands, such as are required to target unique sequences in biological systems (14–16 base pairs), the critical feature is the phasing or spatial correspondence between repeat units in the ligand and the receptor. The recently discovered 2:1 lexitropsin‐DNA binding motif provides a further refinement in molecular recognition in permitting discrimination between GC and CG base pairs. The application of these factors in the design and synthesis of novel agents which exhibit anticancer, antiviral, and antiretroviral properties, and in the inhibition of critical cellular enzymes including topoisomerases, is discussed. The emerging evidence of a relationship between sequence selectivity of the new agents and the biological response they invoke is also described. © 1995 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/ddr.430340207
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002188
- to stream Istex, to step Curation: 002188
- to stream Istex, to step Checkpoint: 001A31
- to stream Main, to step Merge: 004779
- to stream Main, to step Curation: 004057
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Design and development of sequence selective lexitropsin DNA minor groove binders</title><author><name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:ACB89ACF4F4CC8173BA24A745B48156E7DA61FF6</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1002/ddr.430340207</idno><idno type="url">https://api-v5.istex.fr/document/ACB89ACF4F4CC8173BA24A745B48156E7DA61FF6/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002188</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002188</idno><idno type="wicri:Area/Istex/Curation">002188</idno><idno type="wicri:Area/Istex/Checkpoint">001A31</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A31</idno><idno type="wicri:doubleKey">0272-4391:1995:Lown J:design:and:development</idno><idno type="wicri:Area/Main/Merge">004779</idno><idno type="wicri:Area/Main/Curation">004057</idno><idno type="wicri:Area/Main/Exploration">004057</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Design and development of sequence selective lexitropsin DNA minor groove binders</title><author><name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Chemistry, University of Alberta, Edmonton, Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Department of Chemistry, University of Alberta, Edmonton, Alberta</wicri:regionArea><wicri:noRegion>Alberta</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Drug Development Research</title><title level="j" type="abbrev">Drug Dev. Res.</title><idno type="ISSN">0272-4391</idno><idno type="eISSN">1098-2299</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1995-02">1995-02</date><biblScope unit="volume">34</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="145">145</biblScope><biblScope unit="page" to="183">183</biblScope></imprint><idno type="ISSN">0272-4391</idno></series><idno type="istex">ACB89ACF4F4CC8173BA24A745B48156E7DA61FF6</idno><idno type="DOI">10.1002/ddr.430340207</idno><idno type="ArticleID">DDR430340207</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0272-4391</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>DNA minor groove</term><term>anticancer</term><term>antigene</term><term>antiviral</term><term>cancer</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The concept of lexitropsins, or information‐reading molecules, is introduced within the antigene strategy as an alternative to, and complementary with, the antisense approach for cellular intervention and gene control. Consideration is given to alternative approaches to the development of DNA sequence selective binding agents because of their potential applications in diagnosis and treatment of cancer as well as in molecular biology. The chemical, physical, and pharmacological factors involved in the design of effective lexitropsins are discussed and illustrated with experimental results. Among the factors contributing to the molecular recognition processes are: the presence and disposition of hydrogen bond accepting and donating groups, ligand shape, chirality, stereochemistry, flexibility, and charge. For longer ligands, such as are required to target unique sequences in biological systems (14–16 base pairs), the critical feature is the phasing or spatial correspondence between repeat units in the ligand and the receptor. The recently discovered 2:1 lexitropsin‐DNA binding motif provides a further refinement in molecular recognition in permitting discrimination between GC and CG base pairs. The application of these factors in the design and synthesis of novel agents which exhibit anticancer, antiviral, and antiretroviral properties, and in the inhibition of critical cellular enzymes including topoisomerases, is discussed. The emerging evidence of a relationship between sequence selectivity of the new agents and the biological response they invoke is also described. © 1995 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><country name="Canada"><noRegion><name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name></noRegion><name sortKey="Lown, J William" sort="Lown, J William" uniqKey="Lown J" first="J. William" last="Lown">J. William Lown</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004057 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004057 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:ACB89ACF4F4CC8173BA24A745B48156E7DA61FF6
|texte= Design and development of sequence selective lexitropsin DNA minor groove binders
}}
| This area was generated with Dilib version V0.6.29. |  |